Stay updated on iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial

Sign up to get notified when there's something new on the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the study page, signaling a new version of the record. This is a metadata change and does not alter the study’s content.
    Difference
    0.1%
    Check dated 2026-05-18T03:43:53.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page revision label at the bottom changes from v3.5.2 to v3.5.3, indicating a minor site release update without altering the study details.
    Difference
    0.1%
    Check dated 2026-04-26T08:24:00.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision history updated to include v3.5.2 and remove v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T01:38:20.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Updated the page’s revision tag from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T08:48:46.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T20:39:33.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. No user-facing content or study information appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:17:59.000Z thumbnail image

Stay in the know with updates to iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page.